Firdose Nakwa to Amphotericin B
This is a "connection" page, showing publications Firdose Nakwa has written about Amphotericin B.
Connection Strength
0,165
-
A randomized, double-blind trial investigating the efficacy of caspofungin versus amphotericin B deoxycholate in the treatment of invasive candidiasis in neonates and infants younger than 3 months of age. J Antimicrob Chemother. 2020 01 01; 75(1):215-220.
Score: 0,165